Add a Thiazide or Thiazide-Like Diuretic as the Next Step
For a patient already on amlodipine (a calcium channel blocker) and metoprolol (a beta-blocker), the most appropriate third antihypertensive agent to add is a thiazide or thiazide-like diuretic, specifically chlorthalidone or indapamide. This recommendation is based on the most recent international guidelines and represents the standard stepwise approach to uncontrolled hypertension 1.
Rationale for Adding a Diuretic
The 2020 International Society of Hypertension guidelines provide a clear algorithmic approach: after initiating therapy with an ACE inhibitor/ARB or calcium channel blocker (CCB), the next step is to add a thiazide/thiazide-like diuretic 1. Since your patient is already on amlodipine (a dihydropyridine CCB) and metoprolol (a beta-blocker), adding a diuretic completes the foundational triple-therapy combination.
The 2016 and 2020 Canadian Hypertension guidelines similarly recommend that additional antihypertensive drugs should be chosen from first-line options, with useful combinations including a thiazide/thiazide-like diuretic with a CCB (Grade B evidence) 2, 3. The combination of a diuretic with amlodipine and a beta-blocker provides complementary mechanisms of action: volume reduction (diuretic), vasodilation (CCB), and heart rate/cardiac output reduction (beta-blocker).
Specific Diuretic Recommendations
- Chlorthalidone or indapamide are preferred over hydrochlorothiazide due to longer duration of action and superior outcomes data 1, 4
- Start at low doses to minimize adverse effects, particularly hypokalemia 2
- Monitor serum potassium levels, as hypokalemia should be avoided 2, 3
If Blood Pressure Remains Uncontrolled (Resistant Hypertension)
If target blood pressure is not achieved with the triple combination of amlodipine + metoprolol + diuretic, the patient meets criteria for resistant hypertension. At this stage:
Fourth-Line Agent: Mineralocorticoid Receptor Antagonist (MRA)
Add spironolactone as the preferred fourth-line agent 1, 4, 5. The 2025 AHA/ACC guidelines provide Grade A evidence that in adults with uncontrolled resistant hypertension despite optimal triple therapy (including a thiazide-like diuretic) and with eGFR ≥45 mL/min/1.73 m², addition of an MRA is recommended to control blood pressure 4.
Alternative Fourth-Line Options
If spironolactone is not tolerated or contraindicated, consider 1, 4, 5:
- Eplerenone (may require higher doses of 50-200 mg, potentially twice daily)
- Amiloride (potassium-sparing diuretic)
- Doxazosin (alpha-blocker)
- Clonidine (central sympatholytic)
The 2024 ESC guidelines note that vasodilating beta-blockers (labetalol, carvedilol, nebivolol) may be considered as alternatives, though beta-blockade appears less potent than spironolactone in resistant hypertension 5.
Important Caveats and Monitoring
Avoid ACE Inhibitor/ARB Combination
Do not combine an ACE inhibitor with an ARB - this combination is explicitly not recommended due to increased risk of hypotension, hyperkalemia, and worsening renal function without additional benefit 6, 2, 3.
Monitor for Hyperkalemia
When adding a diuretic to existing therapy, and especially when considering spironolactone later, assess risk factors for hyperkalemia 2:
- Patients on renin-angiotensin-aldosterone inhibitors
- Chronic kidney disease (eGFR < 60 mL/min/1.73 m²)
- Baseline potassium > 4.5 mmol/L
- Concurrent medications that raise potassium
Consider Adding an ACE Inhibitor or ARB
While the current regimen includes amlodipine and metoprolol, adding an ACE inhibitor or ARB before or alongside the diuretic may be beneficial, particularly if the patient has:
- Coronary artery disease 6
- Heart failure with reduced ejection fraction 6
- Chronic kidney disease 3
- Diabetes 1
The 2011 Canadian guidelines note that for high-risk patients using combination therapy, the combination of an ACE inhibitor and a dihydropyridine CCB is preferable to an ACE inhibitor and diuretic in selected patients (Grade A) 6.
Practical Algorithm Summary
- Current regimen: Amlodipine + Metoprolol
- Add next: Thiazide-like diuretic (chlorthalidone or indapamide)
- If still uncontrolled: Add spironolactone (if eGFR ≥45)
- Alternatives to spironolactone: Eplerenone, amiloride, doxazosin, or clonidine
- Consider ACE inhibitor/ARB if compelling indications exist (CAD, HF, CKD, diabetes)
Target Blood Pressure
Aim for < 130/80 mmHg in most patients, with individualization based on age, frailty, and comorbidities 1, 3.